Falang Database driver not enabled

Drug development using red blood cells as drug delivery technology for cancer treatments. First product completed successfully its Phase III for the treatment of acute lymphoblastic leukemia.

EXIT in November 2015 : IPO on Euronext Paris (ERYP).